Congrats MASHdoc_SA!! You should be so proud of yourself. 🎉 👏

Clinical perspective on Buyer Beware posting rules read before:

I have managed over 200 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that the medication works best as part of a comprehensive approach.

For this specific question, I would recommend: getting comprehensive baseline labs first.

SarahChen_PharmD said:

You should be so proud of yourself

I respect SarahChen_PharmD perspective but I think this oversimplifies things a bit. Re: Buyer Beware posting rules — the subgroup analyses show meaningful heterogeneity.

I am not saying SarahChen_PharmD wrong entirely — just that the picture is more nuanced than a blanket statement. The SUSTAIN data specifically shows different outcomes in different metabolic phenotypes.

Same experience here with Buyer Beware posting. SarahChen_PharmD described it perfectly.

Want to share my personal experience related to Buyer Beware posting rules since I think it might help others in a similar situation.

I started my GLP-1 journey in March 2025 at 246 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.

Now, 10 months later: I am down 71 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The Buyer Beware posting aspect specifically was something that made a big difference in my journey.

This forum was my go-to resource throughout.